My ePortfolio Register   

3rd Immunotherapy of Cancer Conference (ITOC3) /
Combination of viroimmunotherapy with checkpoint inhibitors

21st - 23rd Mar 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.04.16
Views: 1592
Rating:

Prof Alan Melcher - The Institute of Cancer Research and The Royal Marsden Hospital, London, UK

Prof Alan Melcher speaks with ecancertv about his research into oncolytic viruses as immunotherapy - reprogramming infectious agents to reach inaccessible tumours and stimulate host immune response.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence